<< CSR 1975-2010 Home

The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 85 KB) and Technical Notes (PDF, 282 KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 32.18

SEER Incidencea and U.S. Mortalityb Rates and Trends for the Top 5 Cancer Sitesc by Age

All Races, Males, 1975-2010

Ages 15-19
Site Incidence Mortality
1975-2010 2001-2010 1975-2010 2001-2010
Rate AAPCd Rate AAPCd Rate AAPCd Rate AAPCd
All Malignant Cancers 20.9 0.6* 22.6 0.6* 4.9 -2.3* 3.8 -2.9*
Hodgkin Lymphoma 3.3 -0.6* 3.1 -0.6* 0.2 -5.1* 0.1 -5.1*
Testis 3.1 1.2* 3.6 1.2* 0.2 -6.0* 0.1 -3.7*
Brain and Other Nervous System 2.3 0.2 2.4 0.2 0.7 -1.2* 0.6 -1.2*
Non-Hodgkin Lymphoma 2.0 1.4* 2.3 1.4* 0.5 -3.0* 0.3 -3.0*
Bones and Joints 1.9 0.3 1.9 0.3 0.7 -1.4* 0.6 -0.1
Ages 20-24
Site Incidence Mortality
1975-2010 2001-2010 1975-2010 2001-2010
Rate AAPCd Rate AAPCd Rate AAPCd Rate AAPCd
All Malignant Cancers 33.0 0.5* 35.1 0.5* 6.7 -1.5* 5.6 -0.9*
Testis 8.8 0.9* 10.1 0.9* 0.5 -3.4* 0.3 2.4
Hodgkin Lymphoma 5.0 -0.4 4.6 -0.4 0.5 -4.3* 0.2 -4.3*
Melanoma of the Skin 2.8 0.4 2.9 0.4 0.2 -1.9* 0.2 2.3
Non-Hodgkin Lymphoma 2.6 1.9* 3.2 1.9* 0.7 -1.9* 0.5 -5.0*
Brain and Other Nervous System 2.6 0.1 2.5 0.1 0.7 -0.8* 0.6 -0.8*
Ages 25-29
Site Incidence Mortality
1975-2010 2001-2010 1975-2010 2001-2010
Rate AAPCd Rate AAPCd Rate AAPCd Rate AAPCd
All Malignant Cancers 49.7 0.9* 52.1 1.6* 9.0 -1.4* 7.2 -0.4
Testis 12.5 1.2* 14.4 1.2* 0.7 -3.9* 0.4 -1.9*
Melanoma of the Skin 5.2 0.3 5.5 0.3 0.6 -2.7* 0.4 0.4
Hodgkin Lymphoma 5.1 -0.2 4.7 -0.2 0.7 -4.4* 0.3 -4.4*
Non-Hodgkin Lymphoma 4.4 1.5 4.3 1.8 1.0 -1.7* 0.6 -5.7*
Kaposi sarcoma 4.0 - 1.4 - - - - -
Ages 30-34
Site Incidence Mortality
1975-2010 2001-2010 1975-2010 2001-2010
Rate AAPCd Rate AAPCd Rate AAPCd Rate AAPCd
All Malignant Cancers 70.7 1.0* 68.1 1.0* 13.7 -1.5* 10.7 -1.1*
Testis 12.8 1.9* 14.6 0.5 0.6 -2.9* 0.4 -0.4
Kaposi sarcoma 8.7 - 2.1 - - - - -
Melanoma of the Skin 8.4 0.2 8.7 0.2 1.1 -2.3* 0.7 -2.2*
Non-Hodgkin Lymphoma 7.3 1.7 6.4 2.6 1.5 -1.2 0.9 -3.3
Hodgkin Lymphoma 4.3 0.2 4.4 0.2 0.8 -4.4* 0.4 -5.4*
Ages 35-39
Site Incidence Mortality
1975-2010 2001-2010 1975-2010 2001-2010
Rate AAPCd Rate AAPCd Rate AAPCd Rate AAPCd
All Malignant Cancers 100.6 0.6 96.5 0.3 23.9 -1.6* 18.4 -1.6*
Melanoma of the Skin 12.2 0.7 11.8 -0.7* 1.6 -2.8* 1.0 -4.4*
Testis 11.0 2.0* 12.2 0.5 0.5 -2.9* 0.4 -1.2*
Non-Hodgkin Lymphoma 10.9 3.0* 10.1 0.4 2.1 -1.4* 1.2 -4.8*
Kaposi sarcoma 10.5 - 3.2 - - - - -
Colon and Rectum 7.4 1.2* 9.0 1.2* 2.3 -0.4 2.2 0.4

Footnotes:

Rates are per 100,000.

a SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta).

b US Mortality Files, National Center for Health Statistics, CDC.

c Top 5 cancer sites selected based on 1975-2010 rates for the age group.

d The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint over the time range of 1975-2010.

- Statistic could not be calculated. Count and rate based on less than 16 cases for the time interval. AAPC could not be calculated due to insufficient data.

* The AAPC is significantly different from zero (p<.05).

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.